MEDINA is a member of RICET (Red de Enfermedades Tropicales del ISCIII) and part of the chemotherapy group for infectious diseases. www.ricet.es.
RICET´s main objective is to strengthen translational research in tropical diseases improving the knowledge and enhancing good practices within and outside our country. RICET works on the improvement of diagnosis finding new therapeutic formulas and recommending strategies for prevention. It also conducts depth studies on the relationship between etiological agent of the disease, host and, when appropriate, transmitting vectors.
With one of the most productive collections of filamentous and actinomycetes fungi globally (composed by more than 110,000 strains), an high capacity of High Throughput Screening, as well as platforms for natural products chemistry and ADME Tox, a broad experience in evaluating metabolites candidates, MEDINA´s team has extensive resources and expertise to find innovative therapies in parasitic and infectious diseases such as malaria, leishmaniasis and trypanosomiasis.
